Improving Transparency in Phase 1 Clinical Trials

Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved in phase 1 clinical trials.

Feb 9^th • 29 mins listen

ctDNA Breakthroughs in Mesothelioma Care

Labcorp, Rebecca Previs, Mark Sausen, immunotherapy, mesothelioma, checkpoint blockade, ctDNA, imaging

Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.

Nov 3^rd • 15 mins listen

Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?

If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process …

Jul 22^nd • 3 mins listen